147 related articles for article (PubMed ID: 35119005)
21. Systemic lupus erythematosus associated with development of macrophage activation syndrome and disseminated aspergillosis.
Phoophiboon V; Brown P; Burns KEA
Can J Anaesth; 2023 Jul; 70(7):1255-1260. PubMed ID: 37349668
[TBL] [Abstract][Full Text] [Related]
22. Recurrent macrophage activation syndrome as the initial manifestation of paediatric systemic lupus erythematosus.
Dey S; Roongta R; Mondal S; Haldar S; Sircar G; Ghosh B; Ghosh A
Lupus; 2022 Aug; 31(9):1132-1137. PubMed ID: 35713230
[No Abstract] [Full Text] [Related]
23. Kikuchi-Fujimoto disease as the initial manifestation of systemic lupus erythematosus complicated with macrophage activation syndrome: two case reports and a review of literature.
Liu C; Jin Y; Huang H; Ding F; Yang Z; Xu X; Bao S; Ma J; Jin Y
BMC Pediatr; 2022 Nov; 22(1):673. PubMed ID: 36414954
[TBL] [Abstract][Full Text] [Related]
24. Case of using mycophenolate in combination with steroids for concurrent macrophage activation syndrome and lupus flare.
Shah K; Porter A; Takhar G; Reddy V
BMJ Case Rep; 2020 Apr; 13(4):. PubMed ID: 32269047
[TBL] [Abstract][Full Text] [Related]
25. Macrophage Activation Syndrome.
Sen ES; Clarke SL; Ramanan AV
Indian J Pediatr; 2016 Mar; 83(3):248-53. PubMed ID: 26400031
[TBL] [Abstract][Full Text] [Related]
26. High-dose anakinra as treatment for macrophage activation syndrome caused by refractory Kawasaki disease in an infant.
Lind-Holst M; Hartling UB; Christensen AE
BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31383678
[TBL] [Abstract][Full Text] [Related]
27. Macrophage Activation Syndrome (MAS) in a Recently Released Prisoner with Systemic Lupus Erythematosus (SLE).
Szulawski R; Kourlas PJ; Antonchak M
Am J Case Rep; 2018 Jun; 19():734-738. PubMed ID: 29930239
[TBL] [Abstract][Full Text] [Related]
28. A case of macrophage activation syndrome successfully treated with anakinra.
Kelly A; Ramanan AV
Nat Clin Pract Rheumatol; 2008 Nov; 4(11):615-20. PubMed ID: 18825135
[TBL] [Abstract][Full Text] [Related]
29. Macrophage activation syndrome in children with systemic lupus erythematosus and children with juvenile idiopathic arthritis.
Bennett TD; Fluchel M; Hersh AO; Hayward KN; Hersh AL; Brogan TV; Srivastava R; Stone BL; Korgenski EK; Mundorff MB; Casper TC; Bratton SL
Arthritis Rheum; 2012 Dec; 64(12):4135-42. PubMed ID: 22886474
[TBL] [Abstract][Full Text] [Related]
30. Macrophage activation syndrome: A severe and frequent manifestation of acute pancreatitis in 362 childhood-onset compared to 1830 adult-onset systemic lupus erythematosus patients.
Gormezano NW; Otsuzi CI; Barros DL; da Silva MA; Pereira RM; Campos LM; Borba EF; Bonfá E; Silva CA
Semin Arthritis Rheum; 2016 Jun; 45(6):706-10. PubMed ID: 26833399
[TBL] [Abstract][Full Text] [Related]
31. Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases.
Lin CI; Yu HH; Lee JH; Wang LC; Lin YT; Yang YH; Chiang BL
Clin Rheumatol; 2012 Aug; 31(8):1223-30. PubMed ID: 22615046
[TBL] [Abstract][Full Text] [Related]
32. Macrophage activation syndrome in systemic lupus erythematosus and systemic-onset juvenile idiopathic arthritis: a retrospective study of similarities and dissimilarities.
Naveen R; Jain A; Muhammed H; Gupta L; Misra DP; Lawrence A; Agarwal V; Misra R; Aggarwal A
Rheumatol Int; 2021 Mar; 41(3):625-631. PubMed ID: 33388903
[TBL] [Abstract][Full Text] [Related]
33. Refractory adult-onset Still disease complicated by macrophage activation syndrome and acute myocarditis: A case report treated with high doses (8 mg/kg/d) of anakinra.
Parisi F; Paglionico A; Varriano V; Ferraccioli G; Gremese E
Medicine (Baltimore); 2017 Jun; 96(24):e6656. PubMed ID: 28614216
[TBL] [Abstract][Full Text] [Related]
34. Severe and life-threatening onset of systemic lupus erythematosus.
Martins A; Pimenta S; Oliveira D; Martins F; Samões B; Costa L
Reumatol Clin (Engl Ed); 2023; 19(7):402-403. PubMed ID: 37661117
[TBL] [Abstract][Full Text] [Related]
35. Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies.
Schulert GS; Grom AA
Annu Rev Med; 2015; 66():145-59. PubMed ID: 25386930
[TBL] [Abstract][Full Text] [Related]
36. Rowell Syndrome in Nigeria: Systemic Lupus Erythematosus Presenting as Recurrent Erythema Multiforme in a Young Woman.
Akintayo RO; Olarinoye GM; Akintayo FC; Ilesanmi ON
Acta Dermatovenerol Croat; 2019 Sep; 27(3):200-201. PubMed ID: 31542069
[TBL] [Abstract][Full Text] [Related]
37. Macrophage activation syndrome in adult systemic lupus erythematosus: report of seven adult cases from a single Italian rheumatology center.
Dall'Ara F; Cavazzana I; Frassi M; Taraborelli M; Fredi M; Franceschini F; Andreoli L; Rossi M; Cattaneo C; Tincani A; Airò P
Reumatismo; 2018 Jul; 70(2):100-105. PubMed ID: 29976044
[TBL] [Abstract][Full Text] [Related]
38. Macrophage activation syndrome as an initial presentation of systemic lupus erythematosus with sensorineural hearing loss in a young male patient.
Tan CL; Yahaya MH; Ahmad NS; Lim CH
BMJ Case Rep; 2020 Mar; 13(3):. PubMed ID: 32169986
[TBL] [Abstract][Full Text] [Related]
39. Acute pancreatitis in juvenile systemic lupus erythematosus: a manifestation of macrophage activation syndrome?
Campos LM; Omori CH; Lotito AP; Jesus AA; Porta G; Silva CA
Lupus; 2010 Dec; 19(14):1654-8. PubMed ID: 20837568
[TBL] [Abstract][Full Text] [Related]
40. An unusual case of systemic lupus erythematosus, lupus nephritis, and transient monoclonal gammopathy.
Strobel ES; Fritschka E; Schmitt-Gräff A; Peter HH
Rheumatol Int; 2000; 19(6):235-41. PubMed ID: 11063295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
